Literature DB >> 26695843

Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII-constitutive phosphorylation of RyR2 at site S2814.

G Mazzocchi1, L Sommese1, J Palomeque1, J I Felice1, M N Di Carlo1, D Fainstein1, P Gonzalez2, P Contreras3, D Skapura4, M D McCauley4, E C Lascano5, J A Negroni5, E G Kranias6, X H T Wehrens4, C A Valverde1, A Mattiazzi1.   

Abstract

KEY POINTS: Mice with Ca(2+) -calmodulin-dependent protein kinase (CaMKII) constitutive pseudo-phosphorylation of the ryanodine receptor RyR2 at Ser2814 (S2814D(+/+) mice) exhibit a higher open probability of RyR2, higher sarcoplasmic reticulum (SR) Ca(2+) leak in diastole and increased propensity to arrhythmias under stress conditions. We generated phospholamban (PLN)-deficient S2814D(+/+) knock-in mice by crossing two colonies, S2814D(+/+) and PLNKO mice, to test the hypothesis that PLN ablation can prevent the propensity to arrhythmias of S2814D(+/+) mice. PLN ablation partially rescues the altered intracellular Ca(2+) dynamics of S2814D(+/+) hearts and myocytes, but enhances SR Ca(2+) sparks and leak on confocal microscopy. PLN ablation diminishes ventricular arrhythmias promoted by CaMKII phosphorylation of S2814 on RyR2. PLN ablation aborts the arrhythmogenic SR Ca(2+) waves of S2814D(+/+) and transforms them into non-propagating events. A mathematical human myocyte model replicates these results and predicts the increase in SR Ca(2+) uptake required to prevent the arrhythmias induced by a CaMKII-dependent leaky RyR2. ABSTRACT: Mice with constitutive pseudo-phosphorylation at Ser2814-RyR2 (S2814D(+/+) ) have increased propensity to arrhythmias under β-adrenergic stress conditions. Although abnormal Ca(2+) release from the sarcoplasmic reticulum (SR) has been linked to arrhythmogenesis, the role played by SR Ca(2+) uptake remains controversial. We tested the hypothesis that an increase in SR Ca(2+) uptake is able to rescue the increased arrhythmia propensity of S2814D(+/+) mice. We generated phospholamban (PLN)-deficient/S2814D(+/+) knock-in mice by crossing two colonies, S2814D(+/+) and PLNKO mice (SD(+/+) /KO). SD(+/+) /KO myocytes exhibited both increased SR Ca(2+) uptake seen in PLN knock-out (PLNKO) myocytes and diminished SR Ca(2+) load (relative to PLNKO), a characteristic of S2814D(+/+) myocytes. Ventricular arrhythmias evoked by catecholaminergic challenge (caffeine/adrenaline) in S2814D(+/+) mice in vivo or programmed electric stimulation and high extracellular Ca(2+) in S2814D(+) /(-) hearts ex vivo were significantly diminished by PLN ablation. At the myocyte level, PLN ablation converted the arrhythmogenic Ca(2+) waves evoked by high extracellular Ca(2+) provocation in S2814D(+/+) mice into non-propagated Ca(2+) mini-waves on confocal microscopy. Myocyte Ca(2+) waves, typical of S2814D(+/+) mice, could be evoked in SD(+/+) /KO cells by partially inhibiting SERCA2a. A mathematical human myocyte model replicated these results and allowed for predicting the increase in SR Ca(2+) uptake required to prevent the arrhythmias induced by a Ca(2+) -calmodulin-dependent protein kinase (CaMKII)-dependent leaky RyR2. Our results demonstrate that increasing SR Ca(2+) uptake by PLN ablation can prevent the arrhythmic events triggered by SR Ca(2+) leak due to CaMKII-dependent phosphorylation of the RyR2-S2814 site and underscore the benefits of increasing SERCA2a activity on SR Ca(2+) -triggered arrhythmias.
© 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26695843      PMCID: PMC4887664          DOI: 10.1113/JP271622

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  60 in total

1.  β-adrenergic effects on cardiac myofilaments and contraction in an integrated rabbit ventricular myocyte model.

Authors:  Jorge A Negroni; Stefano Morotti; Elena C Lascano; Aldrin V Gomes; Eleonora Grandi; José L Puglisi; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2015-02-25       Impact factor: 5.000

2.  Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure.

Authors:  Ralph J van Oort; Mark D McCauley; Sayali S Dixit; Laetitia Pereira; Yi Yang; Jonathan L Respress; Qiongling Wang; Angela C De Almeida; Darlene G Skapura; Mark E Anderson; Donald M Bers; Xander H T Wehrens
Journal:  Circulation       Date:  2010-11-15       Impact factor: 29.690

3.  A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia.

Authors:  Guan-Sheng Liu; Ana Morales; Elizabeth Vafiadaki; Chi Keung Lam; Wen-Feng Cai; Kobra Haghighi; George Adly; Ray E Hershberger; Evangelia G Kranias
Journal:  Cardiovasc Res       Date:  2015-04-07       Impact factor: 10.787

4.  Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes.

Authors:  Yanxia Li; Evangelia G Kranias; Gregory A Mignery; Donald M Bers
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

5.  Reduced SERCA2 abundance decreases the propensity for Ca2+ wave development in ventricular myocytes.

Authors:  Mathis K Stokke; Karina Hougen; Ivar Sjaastad; William E Louch; Sarah J Briston; Ulla H Enger; Kristin B Andersson; Geir Christensen; David A Eisner; Ole M Sejersted; Andrew W Trafford
Journal:  Cardiovasc Res       Date:  2009-12-17       Impact factor: 10.787

6.  Computer model of action potential of mouse ventricular myocytes.

Authors:  Vladimir E Bondarenko; Gyula P Szigeti; Glenna C L Bett; Song-Jung Kim; Randall L Rasmusson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05-13       Impact factor: 4.733

Review 7.  Mechanisms and potential therapeutic targets for ventricular arrhythmias associated with impaired cardiac calcium cycling.

Authors:  Kenneth R Laurita; David S Rosenbaum
Journal:  J Mol Cell Cardiol       Date:  2007-10-25       Impact factor: 5.000

8.  The signalling pathway of CaMKII-mediated apoptosis and necrosis in the ischemia/reperfusion injury.

Authors:  Margarita A Salas; Carlos A Valverde; Gina Sánchez; Matilde Said; Jesica S Rodriguez; Enrique L Portiansky; Marcia A Kaetzel; John R Dedman; Paulina Donoso; Evangelia G Kranias; Alicia Mattiazzi
Journal:  J Mol Cell Cardiol       Date:  2010-01-06       Impact factor: 5.000

Review 9.  Prevalence and incidence of arrhythmias and sudden death in heart failure.

Authors:  John G F Cleland; Sudipta Chattopadhyay; Aleem Khand; Timothy Houghton; Gerald C Kaye
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

Review 10.  Cardiac sarcoplasmic reticulum calcium leak: basis and roles in cardiac dysfunction.

Authors:  Donald M Bers
Journal:  Annu Rev Physiol       Date:  2013-11-13       Impact factor: 19.318

View more
  14 in total

Review 1.  SERCA2a: a key protein in the Ca2+ cycle of the heart failure.

Authors:  Liu Zhihao; Ni Jingyu; Li Lan; Sarhene Michael; Guo Rui; Bian Xiyun; Liu Xiaozhi; Fan Guanwei
Journal:  Heart Fail Rev       Date:  2020-05       Impact factor: 4.214

2.  Balancing SR Ca(2+) uptake and release in the cycle of heart rhythm.

Authors:  D R Laver
Journal:  J Physiol       Date:  2016-06-01       Impact factor: 5.182

3.  Ca2+/calmodulin-dependent kinase II-dependent regulation of atrial myocyte late Na+ current, Ca2+ cycling, and excitability: a mathematical modeling study.

Authors:  Birce Onal; Daniel Gratz; Thomas J Hund
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-25       Impact factor: 4.733

Review 4.  Interactive Roles of CaMKII/Ryanodine Receptor Signaling and Inflammation in Lung Diseases.

Authors:  Lan Wang; Roman G Ginnan; Yong-Xiao Wang; Yun-Min Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Calcium-calmodulin-dependent protein kinase mediates the intracellular signalling pathways of cardiac apoptosis in mice with impaired glucose tolerance.

Authors:  Marilen Federico; Enrique L Portiansky; Leandro Sommese; Francisco J Alvarado; Paula G Blanco; Carolina N Zanuzzi; John Dedman; Marcia Kaetzel; Xander H T Wehrens; Alicia Mattiazzi; Julieta Palomeque
Journal:  J Physiol       Date:  2017-03-02       Impact factor: 5.182

6.  Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.

Authors:  Carlos A Valverde; Gabriela Mazzocchi; Mariano N Di Carlo; Alejandro Ciocci Pardo; Nehuen Salas; María Ines Ragone; Juan I Felice; Alejandra Cely-Ortiz; Alicia E Consolini; Enrique Portiansky; Susana Mosca; Evangelia G Kranias; Xander H T Wehrens; Alicia Mattiazzi
Journal:  Cardiovasc Res       Date:  2019-03-01       Impact factor: 10.787

7.  In vivo Overexpression of Electrogenic Sodium/Bicarbonate Cotransporter (NBCe1) by AAV9 Modifies the Cardiac Action Potential and the QT Interval in Mice.

Authors:  Romina A Di Mattía; Leandro A Díaz Zegarra; Carlos A Valverde; Paula G Blanco; Carolina Jaquenod De Giusti; Enrique L Portiansky; Ernesto A Aiello; Alejandro Orlowski
Journal:  Front Cardiovasc Med       Date:  2022-04-25

Review 8.  Unbalance Between Sarcoplasmic Reticulum Ca2 + Uptake and Release: A First Step Toward Ca2 + Triggered Arrhythmias and Cardiac Damage.

Authors:  Marilén Federico; Carlos A Valverde; Alicia Mattiazzi; Julieta Palomeque
Journal:  Front Physiol       Date:  2020-01-23       Impact factor: 4.566

Review 9.  When signalling goes wrong: pathogenic variants in structural and signalling proteins causing cardiomyopathies.

Authors:  Mehroz Ehsan; He Jiang; Kate L Thomson; Katja Gehmlich
Journal:  J Muscle Res Cell Motil       Date:  2017-11-08       Impact factor: 2.698

10.  Conditional Up-Regulation of SERCA2a Exacerbates RyR2-Dependent Ventricular and Atrial Arrhythmias.

Authors:  Bin Liu; Qing Lou; Heather Smith; Florencia Velez-Cortes; Wolfgang H Dillmann; Björn C Knollmann; Antonis A Armoundas; Sándor Györke
Journal:  Int J Mol Sci       Date:  2020-04-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.